Vascular Stent Market Size by projects the Vascular Stent, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2032
Overview
Vascular Stent Market is expected to reach USD 19.18 Bn. at a CAGR of 6.7%, by 2032.
Vascular stents are tubular scaffolds, which are used in the treatment of arterial stenosis. It helps to prevent acute vessel closure in a variety of vessels.
Vascular Stent Market, Dynamics:
The current shift in the demographic structure caused by the aging of society is expected to increase the adoption of the stents rapidly. An increase in vascular disease is expected to drive the demand in the near future. The stenting technology has increasingly preferred over conventional balloon angioplasty because of the introduction of advanced DES and growing bioresorbable scaffolds. Currently, advanced technologies deliver the promise of improvement on existing, life-saving and life-improving interventional procedures. The technology advancements like the development of bifurcated stents and the use of biodegradable materials are expected to drive the global vascular stent market growth.
On the other hand, the Existence of alternative treatment methods for CAD, strict regulations for product approval and effects of product failure are some of the factors that are expected to limit the global vascular stent market growth during the forecast period. The report covers the detailed analysis of the drivers and restraints by region. The report also covers the revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers, and market disrupters in the report and the same is reflected in our analysis.
To know about the Research Methodology :- Request Free Sample Report
Vascular Stent Market, Segment Analysis:
The coronary stents segment is expected to contribute xx% share in the global vascular stent market. A coronary stent is a tube, which is used to open a narrowed arteries during a percutaneous coronary intervention procedure (PCI). Coronary stents offer a suitable solution for the treatment of cardiac diseases, such as myocardial infarction, angina pain, and coronary artery disease. The Coronary Stents is expected to grow at 9.10 % during the forecast period. An introduction of innovation in coronary stents are expected to drive its demand in the near future.
The Bare-Metal Stents held the dominant position in the global vascular stent market and is projected to hold its dominant position during the forecast period. Despite the advancement in DES is substituting the usage of BMS is widely used in many PCI procedures because of its low cost and low hospitalization rates.
Vascular Stent Market, Regional Analysis:
North America region is expected to contribute xx% share in the global vascular stent market. The presence of the well-established healthcare infrastructure, an introduction of the technological advancements in coronary stent technologies by the prominent key players are expected to drive the regional growth. The region is an early adopter of the technology. The sedentary lifestyle is one of the key drivers in the market growth, which is resulting in obesity and other cardiovascular diseases like heart attack, stroke, and ischemic heart diseases (IHD). Growth in the prevalence of cardiac diseases is expected to boost the demand for the vascular stent across the region.
Vascular Stent Market, Competitive Analysis:
Some of the prominent companies are proactively involved in product developments and partnerships to increase their market share. Key players are focusing on the development of the technologically advanced DES, which is boosting the market growth. Also, key companies have involved in numerous clinical trials to analyze the treatment outcome of novel stents, which are bioresorbable.
The objective of the report is to present a comprehensive analysis of the Global Vascular Stent Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Vascular Stent Market dynamics, structure by analyzing the market segments and projects the Global Vascular Stent Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Vascular Stent Market make the report investor’s guide.
Recent Industry Developments (2025–2026)
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 03 February 2026 | Medtronic plc | The company announced its intent to acquire CathWorks to advance its interventional innovation strategy. | The acquisition is set to bolster Medtronic's interventional pipeline and expand its capabilities in coronary artery disease assessment. |
| 15 January 2026 | Boston Scientific | The company entered a definitive agreement to acquire Penumbra, Inc. for approximately $11 billion. | This acquisition provides a scaled entry into mechanical thrombectomy and neurovascular segments, significantly expanding the company’s cardiovascular portfolio. |
| 07 July 2025 | Boston Scientific | The U.S. FDA approved expanded labeling for the FARAPULSE Pulsed Field Ablation (PFA) System. | The approval allows for the treatment of drug refractory symptomatic persistent atrial fibrillation, broadening the clinical utility of the system. |
| 20 June 2025 | Abbott | The company received FDA approval for Esprit BTK, a first-of-its-kind dissolving stent for chronic limb-threatening ischemia. | This innovation provides a new standard of care for below-the-knee treatments, reducing disease progression and improving outcomes without a permanent implant. |
| 21 May 2025 | Biotronik | A randomized trial evaluating the Pantera Lux drug-coated balloon (DCB) in combination with Resorbable Magnesium Scaffolds was presented at EuroPCR. | The study demonstrates the efficacy of scaffold-based technologies as an alternative to traditional drug-eluting stents in complex chronic total occlusions. |
| 16 April 2025 | Abbott | The company initiated the TECTONIC U.S. pivotal trial to evaluate its Coronary Intravascular Lithotripsy (IVL) System. | The system is designed to treat severely calcified coronary arteries before stent implantation, improving the safety and expansion of vascular stents. |
Vascular Stent Market Scope: Inquire before buying
| Vascular Stent Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 12.18 USD Bn |
| Forecast Period 2026-2032 CAGR: | 6.7% | Market Size in 2032: | 19.18 USD Bn |
| Segments Covered: | by Product | Drug-Eluting Stents Bare-Metal Stents Bioabsorbable Stents |
|
| by Type | • Coronary Stents • Peripheral Stents o Carotid Stents o Renal Artery Stents o Femoral Stents o Iliac Stents o Other Peripheral stents • EVAR Stent Grafts o Abdominal Aortic Aneurysm o Thoracic Aortic Aneurysm |
||
| by Mode of Delivery | Balloon-Expandable Stents Self-Expanding Stents |
||
| by End User | Hospitals and Cardiac Centers Ambulatory Surgical Centers |
||
Global Vascular Stent Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key players/competitors profile covered in Vascular Stent Market report in strategic perspective
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik SE & Co. KG
Terumo Corporation
Microport Scientific Corporation
B. Braun Melsungen AG
Cook Medical
W. L. Gore & Associates
Meril Life Sciences
Sahajanand Medical Technologies
Translumina
Lepu Medical Technology
Endologix
Getinge Group
AngioDynamics
Cardiovascular Systems, Inc.
Vascular Solutions
Olympus Corporation
Merit Medical Systems
iVascular
Avinger
Spectranetics
Stentys
Elixir Medical Corporation